Status:
RECRUITING
Monitoring of Cerebral Blood Flow in Patients on Extracorporeal Membrane Oxygenation
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions:
Extracorporeal Membrane Oxygenation Complication
Cerebral Circulatory Failure
Eligibility:
All Genders
18-100 years
Brief Summary
Venovenous extracorporeal membrane oxygenation (VV-ECMO) is a supportive therapy, indicated in case of severe, possibly reversible pulmonary failure, refractory to conventional therapies. Despite adva...
Eligibility Criteria
Inclusion
- in order to be eligible to participate in this study, a subject must meet all of the following criteria:
- High suspicion of an indication for VV-ECMO;
- Arterial line present to enable blood sampling;
- Older than 18 years.
Exclusion
- Subjects will be excluded if the cerebral blood flow cannot be measured using the transcranial Doppler
- VA-ECMO or ECPR;
- No possibility for neuromonitoring measurements due to technical difficulties, e.g. post-craniotomy, unsuitable transcranial window;
- No possibility for neuromonitoring measurements due to circumstantial difficulties, e.g. ECPR;
- Contraindications for ECMO;
- ECMO is initiated in another center.
Key Trial Info
Start Date :
December 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 15 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05303363
Start Date
December 15 2021
End Date
August 15 2025
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC
Amsterdam-Zuidoost, Netherlands, 1105